Katarzyna Łosińska (K Łosińska)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 14

Top Topics

Prostate Cancer

Disease Activity

Radical Prostatectomy

Rheumatoid Arthritis Patients

Top Venues

Rheumatology international

Arthritis care & research

Scandinavian journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Mateusz Wilk, Brigitte Michelsen, Katarzyna Łosińska, Arthur Kavanaugh, Mariusz Korkosz, Glenn Haugeberg
Exploring 5-year changes in general and skin health-related quality of life in psoriatic arthritis patients. Rheumatology international (2024)
Mateusz Wilk, Brigitte Michelsen, Katarzyna Łosińska, Arthur Kavanaugh, Mariusz Korkosz, Glenn Haugeberg
Exploring 5-year changes in general and skin health-related quality of life in psoriatic arthritis patients. Rheumatology international 44 (4) (2024)
Are Hugo Pripp, Katarzyna Łosińska, Mariusz Korkosz, Glenn Haugeberg
A practical guide to estimating treatment effects in patients with rheumatic diseases using real-world data. Rheumatology international (2024)
Katarzyna Łosińska, Are Hugo Pripp, Gunnstein Bakland, Bjørg-Tilde Svanes Fevang, Lene Kristin Brekke, Ada Wierød, Mariusz Korkosz, Glenn Haugeberg
Comparative Effectiveness and Persistence of SB4 and Reference Etanercept in Patients With Psoriatic Arthritis in Norway. Arthritis care & research 76 (9) (2024)
Katarzyna Łosińska, Are Hugo Pripp, Gunnstein Bakland, Bjørg-Tilde Svanes Fevang, Lene Kristin Brekke, Ada Wierød, Mariusz Korkosz, Glenn Haugeberg
Comparative effectiveness and persistence of SB4 and reference etanercept in patients with psoriatic arthritis in Norway. Arthritis care & research (2024)
Are Hugo Pripp, Katarzyna Łosińska, Mariusz Korkosz, Glenn Haugeberg
A practical guide to estimating treatment effects in patients with rheumatic diseases using real-world data. Rheumatology international 44 (7) (2024)
Are Hugo Pripp, Katarzyna Łosińska, Mariusz Korkosz, Glenn Haugeberg
A practical guide to estimating treatment effects in patients with rheumatic diseases using real-world data. Rheumatology international 44 (7) (2024)
Are Hugo Pripp, Katarzyna Łosińska, Mariusz Korkosz, Glenn Haugeberg
A practical guide to estimating treatment effects in patients with rheumatic diseases using real-world data. Rheumatology international 44 (7) (2024)
Katarzyna Łosińska, Are Hugo Pripp, Gunnstein Bakland, Bjørg-Tilde Svanes Fevang, Lene Kristin Brekke, Ada Wierød, Mariusz Korkosz, Glenn Haugeberg
Comparative Effectiveness and Persistence of SB4 and Reference Etanercept in Patients With Psoriatic Arthritis in Norway. Arthritis care & research (2024)
Mateusz Wilk, Brigitte Michelsen, Katarzyna Łosińska, Arthur Kavanaugh, Mariusz Korkosz, Glenn Haugeberg
Exploring 5-year changes in general and skin health-related quality of life in psoriatic arthritis patients. Rheumatology international 44 (4) (2024)
Katarzyna Łosińska, Mariusz Korkosz, Are Hugo Pripp, Glenn Haugeberg
Real-world experience of rituximab biosimilar GP2013 in rheumatoid arthritis patients naïve to or switched from reference rituximab. Rheumatology international (2023)
Katarzyna Łosińska, Brigitte Michelsen, Arthur Kavanaugh, Mariusz Korkosz, Glenn Haugeberg
Psoriatic arthritis: improvement in outcomes but persistent sex difference - 5-year follow-up study of a Norwegian outpatient clinic population. Scandinavian journal of rheumatology (2023)
Katarzyna Łosińska, Mariusz Korkosz, Are Hugo Pripp, Glenn Haugeberg
Real-world experience of rituximab biosimilar GP2013 in rheumatoid arthritis patients naïve to or switched from reference rituximab. Rheumatology international (2023)
Mateusz Wilk, Katarzyna Łosińska, Are Hugo Pripp, Mariusz Korkosz, Glenn Haugeberg
Pain catastrophizing in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: biopsychosocial perspective and impact on health-related quality of life. Rheumatology international 42 (4) (2022)